BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Breast Cancer, Retina, Holistic medicine, Lipopolysaccharide, rs4950928, SIRT1)
Bookmark Forward

QuickView for DUSP6;jsessionid=A15DDDBE3FE8817DFFA7EC85659559D5 (gene)


Body Atlas

Most Correlated Tissues

  1. Basophil of peripheral blood
  2. Myeloid cells of peripheral blood
  3. Monocyte of peripheral blood
  4. Parotid gland
  5. Macrophage of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Multiple-resistant Staphylococcus aureus infection
  2. Hemorrhagic shock
  3. Disease due to Orthopoxvirus
  4. Dehydration
  5. Vaccination status
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. anthrax lethal factor
  2. erlotinib
  3. dabrafenib
  4. Trametinib
  5. 5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. SP5
  2. HUNK
  3. CLDN1
  4. B2M
  5. FGFR3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. A DUSP6 inhibitor suppresses inflammatory cardiac remodeling and improves heart function after myoca…
  2. BOP1 Promotes Prostate Cancer through the DUSP6/MAPK Pathway.
  3. Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and e…
  4. LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-…
  5. Acute Endoplasmic Reticulum Stress Suppresses Hepatic Gluconeogenesis by Stimulating MAPK Phosphatas…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for DUSP6;jsessionid=A15DDDBE3FE8817DFFA7EC85659559D5
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.